Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
QF
QVT Financial
New York
| $1.81B | -$19.9M | 6 | 48.33% | Reduced |
|
| 27 |
Dimensional Fund Advisors
Austin,
Texas
| $1.68B | +$26.3M | 31 | 0.78% | Increased |
|
| 28 |
Jennison Associates
New York
| $1.65B | +$115M | 12 | 1.75% | Increased |
|
| 29 |
UBS Group
Zurich,
Switzerland
| $1.58B | +$54.7M | 72 | 0.82% | Increased |
|
| 30 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $1.53B | +$130M | 12 | 3.61% | Increased |
|
| 31 |
TS
Third Security
Radford,
Virginia
| $1.51B | +$2.94M | 2 | 76.65% | Increased |
|
| 32 |
ClearBridge Investments
New York
| $1.5B | +$29.3M | 15 | 1.47% | Increased |
|
| 33 |
Parnassus Investments
San Francisco,
California
| $1.49B | +$80.6M | 2 | 6.28% | Increased |
|
| 34 |
Ameriprise
Minneapolis,
Minnesota
| $1.39B | -$65M | 23 | 0.7% | Reduced |
|
| 35 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1.36B | -$139M | 63 | 0.97% | Reduced |
|
| 36 |
TIAA CREF Investment Management
New York
| $1.27B | +$121M | 39 | 0.89% | Increased |
|
| 37 |
Brown Advisory
Baltimore,
Maryland
| $1.21B | +$43.7M | 11 | 3.71% | Increased |
|
| 38 |
Pictet Asset Management (UK)
London,
United Kingdom
| $1.19B | +$33.6M | 11 | 3.65% | Increased |
|
| 39 |
Legal & General Group
London,
United Kingdom
| $1.07B | +$36.8M | 41 | 0.87% | Increased |
|
| 40 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1.07B | +$125M | 50 | 1.3% | Increased |
|
| 41 |
UBS AM
Chicago,
Illinois
| $1.02B | -$122M | 20 | 0.99% | Reduced |
|
| 42 |
American Century Companies
Kansas City,
Missouri
| $1.01B | +$17.1M | 14 | 1.05% | Increased |
|
| 43 |
Royal Bank of Canada
Toronto,
Ontario, Canada
| $988M | +$64.9M | 55 | 0.51% | Increased |
|
| 44 |
Putnam Investments
Boston,
Massachusetts
| $971M | +$80M | 8 | 2.27% | Increased |
|
| 45 |
Charles Schwab
San Francisco,
California
| $966M | +$62.6M | 41 | 0.91% | Increased |
|
| 46 |
Artisan Partners
Milwaukee,
Wisconsin
| $964M | +$12.8M | 1 | 1.81% | Increased |
|
| 47 |
Edgewood Management
Greenwich,
Connecticut
| $918M | -$131M | 1 | 4.5% | Reduced |
|
| 48 |
Swiss National Bank
Zurich,
Switzerland
| $895M | +$22.7M | 30 | 1.06% | Increased |
|
| 49 |
Brown Brothers Harriman & Co
New York
| $852M | -$51M | 8 | 4.62% | Reduced |
|
| 50 |
OrbiMed
New York
| $851M | +$71.3M | 15 | 8.92% | Increased |
|